Evidence map›Paper›PMID 26958506›Full record

ReviewTranslational lung cancer research2016

PiggyBac transposon vectors: the tools of the human gene encoding.

Shuang Zhao, Enze Jiang, Shuangshuang Chen, Yuan Gu, Anna Junjie Shangguan, Tangfeng Lv, Liguo Luo, Zhenghong Yu

Registry-linked trialAbstract readReview
In one paragraph

Review in Translational lung cancer research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05054257 (Safety and Efficacy of Anti-CD19 Chimeric Antigen Receptor-modified Autologous T Cells), which is not on this map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05054257 phase1recruitingnot on this mapstarted 2021, after this paper: background citation

Safety and Efficacy of Anti-CD19 Chimeric Antigen Receptor-modified Autologous T Cells (CART19) in Patients with Relapsed/refractory CD19+ Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma. a Dose Escalation, Open-label, Phase I Study.

TypeinterventionalSponsorInstitute of Hematology and Blood Transfusion, Czech RepublicRan2021 to 2025Enrolled10ConditionsRelapsed or Refractory B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Refractory, Non-Hodgkin's Lymphoma, RelapsedArmsAutologous CAR19 T lymphocytes
3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Defining thebioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. A Manual for Genome and Transcriptome Engineering.IEEE reviews in biomedical engineering · 2025
    Review
  15. Article
  16. The restricted N-glycome of neurons is programmed during differentiation.bioRxiv : the preprint server for biology · 2024
    Article
  17. Targeted gene delivery systems for T-cell engineering.Cellular oncology (Dordrecht, Netherlands) · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shuang Zhao1 Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China ; 2 Department of Medical Oncology, Jinling Hospital, Nanjing University of Chinese Medicine, Nanjing 210002, China ; 3 Shanghai Medical College of Fudan University, Shanghai 20032, China ; 4 Weinberg College of Arts and Sciences at Northwestern University, Evanston, Illinois 60204, USA ; 5 Department of Respiratory Medicine, 6 Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing 210002, China.
Enze Jiang1 Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China ; 2 Department of Medical Oncology, Jinling Hospital, Nanjing University of Chinese Medicine, Nanjing 210002, China ; 3 Shanghai Medical College of Fudan University, Shanghai 20032, China ; 4 Weinberg College of Arts and Sciences at Northwestern University, Evanston, Illinois 60204, USA ; 5 Department of Respiratory Medicine, 6 Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing 210002, China.
Shuangshuang Chen1 Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China ; 2 Department of Medical Oncology, Jinling Hospital, Nanjing University of Chinese Medicine, Nanjing 210002, China ; 3 Shanghai Medical College of Fudan University, Shanghai 20032, China ; 4 Weinberg College of Arts and Sciences at Northwestern University, Evanston, Illinois 60204, USA ; 5 Department of Respiratory Medicine, 6 Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing 210002, China.
Yuan Gu1 Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China ; 2 Department of Medical Oncology, Jinling Hospital, Nanjing University of Chinese Medicine, Nanjing 210002, China ; 3 Shanghai Medical College of Fudan University, Shanghai 20032, China ; 4 Weinberg College of Arts and Sciences at Northwestern University, Evanston, Illinois 60204, USA ; 5 Department of Respiratory Medicine, 6 Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing 210002, China.
Anna Junjie Shangguan1 Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China ; 2 Department of Medical Oncology, Jinling Hospital, Nanjing University of Chinese Medicine, Nanjing 210002, China ; 3 Shanghai Medical College of Fudan University, Shanghai 20032, China ; 4 Weinberg College of Arts and Sciences at Northwestern University, Evanston, Illinois 60204, USA ; 5 Department of Respiratory Medicine, 6 Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing 210002, China.
Tangfeng Lv1 Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China ; 2 Department of Medical Oncology, Jinling Hospital, Nanjing University of Chinese Medicine, Nanjing 210002, China ; 3 Shanghai Medical College of Fudan University, Shanghai 20032, China ; 4 Weinberg College of Arts and Sciences at Northwestern University, Evanston, Illinois 60204, USA ; 5 Department of Respiratory Medicine, 6 Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing 210002, China.
Liguo Luo1 Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China ; 2 Department of Medical Oncology, Jinling Hospital, Nanjing University of Chinese Medicine, Nanjing 210002, China ; 3 Shanghai Medical College of Fudan University, Shanghai 20032, China ; 4 Weinberg College of Arts and Sciences at Northwestern University, Evanston, Illinois 60204, USA ; 5 Department of Respiratory Medicine, 6 Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing 210002, China.
Zhenghong Yu1 Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China ; 2 Department of Medical Oncology, Jinling Hospital, Nanjing University of Chinese Medicine, Nanjing 210002, China ; 3 Shanghai Medical College of Fudan University, Shanghai 20032, China ; 4 Weinberg College of Arts and Sciences at Northwestern University, Evanston, Illinois 60204, USA ; 5 Department of Respiratory Medicine, 6 Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing 210002, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A transposon is a DNA segment, which is able to change its relative position within the entire genome of a cell. The piggyBac (PB) transposon is a movable genetic element that efficiently transposes between vectors and chromosomes through a "cut-and-paste" mechanism. During transposition, the PB transposase recognizes transposon-specific inverted terminal repeats (ITRs) sequences located on both ends of the transposon vector and eight efficiently moves the contents from its original positions and efficiently integrates them into TTAA chromosomal sites. PB has drawn much attention because of its transposition efficiency, safety and stability. Due to its priorities, PB can be used as a new genetic vehicle, a new tool for oncogene screening and a new method for gene therapy. PB has created a new outlook for human gene encoding.

Indexed as

PiggyBac (PB)transgenetransposon

Identifiers

PMID26958506
PMCPMC4758974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.